4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-25-000003
Chairperson & CEO sold 8,000 shares at an average $398.55 ($3,188,374)
- Chairperson & CEO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $120.26 | $962,080 | 8,130 | D |
| 2025-09-09 | Sale : show line 2 in the form 10b5-1 | −6,165 | $398.29 | $2,455,427 | 1,965 | D |
| 2025-09-09 | Sale : show line 3 in the form 10b5-1 | −1,835 | $399.43 | $732,947 | 130 | D |
| Open-market sales · 8,000 sh · avg $398.55 · $3,188,374 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-09-09 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option | −8,000 | $120.26 | 2026-03-15 | 8,000 | 286,000 | D |
Loading xslF345X05/primarydocument.xml…